- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04567394
Cannabis Use Disorder Treatment Study
December 7, 2022 updated by: Michael Mason, The University of Tennessee, Knoxville
Treating Young Adult Cannabis Use Disorder With Text Message-Delivered Peer Network Counseling
The purpose of this study is to test a text-delivered counseling program to stop or reduce cannabis use among young adults (ages 18 to 25).
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Detailed Description
After being informed about the study and potential risks, participants will complete online screening assessments.
Those who are determined to be eligible via online screening will complete a urine drug screen to confirm eligibility.
Once eligibility is confirmed, participants will be randomized either to the intervention group or to the wait-list control group.
Those who are randomized to the intervention group will receive the 4-week text intervention via smartphone and complete assessments (including urine drug screens) at baseline, 1 month, 3 months, and 6 months.
Those who are randomized to the wait-list control group will only complete the assessments (including urine drug screens) at baseline, 1 month, 3 months, and 6 months.
Participants who are initially assigned to the wait-list control group can choose to receive the text intervention once their 6-month participation is complete.
Study Type
Interventional
Enrollment (Actual)
1077
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Fort Collins, Colorado, United States, 80523
- Colorado State University
-
-
Tennessee
-
Knoxville, Tennessee, United States, 37996
- University of Tennessee Knoxvile
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 18 to 25 years old.
- use of cannabis three or more days during a typical week.
- a score of at least eight on the Cannabis Use Disorder Identification Test-Revised
- a urine specimen positive for cannabis metabolites.
- a score of at least two on the Mini International Neuropsychiatric Interview: Version 7.0.2 for DSM-V, Substance Use Disorder
- must live in Tennessee or Colorado
Exclusion Criteria:
- substance abuse treatment during the past three months.
- lack of access to a text-capable phone.
- unable or unwilling to commit to six months of follow-up.
- not fluent in English.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention
Participants randomized to the Intervention group will complete questionnaires at baseline, 1 month, 3 months, and 6 months and will receive 4 weeks of the PNC-txt intervention.
|
4-week text counseling program
Other Names:
|
No Intervention: Waitlist Control
Participants randomized to the waitlist control group will complete questionnaires at baseline, 1 month, 3 months, and 6 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from Baseline in Tetrahydrocannabinol (Delta-9-THC-COOH) levels
Time Frame: Baseline, 1 month, 3 months, 6 months
|
Urine THC levels (50ng/mL, 100ng/mL, 200ng/mL, 300ng/mL) will provide a biological measure for current cannabis use.
|
Baseline, 1 month, 3 months, 6 months
|
Change in Past 30-Day Cannabis Use
Time Frame: Baseline, 1 month, 3 months, 6 months
|
Past-30-day substance use (cannabis, alcohol, tobacco, other drugs) and consequences are measured using the Alcohol, Smoking and Substance Involvement Screening Test
|
Baseline, 1 month, 3 months, 6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Environmental Risk Assessment
Time Frame: Baseline, 1 month, 3 months, 6 months
|
Participants will report using the Ecological Momentary Assessment reporting about Craving (0=none-10= intense), Cannabis Use (0=none-10= a lot), Mood (0=very good-10= very depressed), and Stress (0=no stress-10 = very stressed) on a 10 point scale for each item
|
Baseline, 1 month, 3 months, 6 months
|
Change in Young Adult Social Network Assessment
Time Frame: Baseline, 1 month, 3 months, 6 months
|
Participants report information on each their 3 closest friends, representing their egocentric network.
Individual friend scores are totaled based on all 8 risky and prosocial items (2-9).
Thus, each peer's score has a potential range from -32 to 32, with greater scores indicating a healthier relationship.
The total peer network health scores is based on the sum of all 24 risky and prosocial items across all three friends.
Assuming three peers per participant, total network quality scores may range from -96 to 96, with lower scores indicating greater network risk and higher scores indicating greater network protection.
|
Baseline, 1 month, 3 months, 6 months
|
Cost Measures
Time Frame: 6 months
|
Cost of intervention implementation will be compared to typical treatment cost for cannabis use disorder
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Michael J Mason, Ph.D., University of Tennessee, Knoxville
- Principal Investigator: J. Douglas Coatsworth, Ph.D., University of Tennessee, Knoxville
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 7, 2020
Primary Completion (Anticipated)
May 31, 2024
Study Completion (Anticipated)
June 30, 2024
Study Registration Dates
First Submitted
September 21, 2020
First Submitted That Met QC Criteria
September 21, 2020
First Posted (Actual)
September 28, 2020
Study Record Updates
Last Update Posted (Estimate)
December 8, 2022
Last Update Submitted That Met QC Criteria
December 7, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1R01DA044206-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cannabis Use Disorder, Mild
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingCannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereUnited States
-
Oregon Research InstituteCompletedCannabis Use Disorder, Mild | Cannabis Use Disorder, ModerateUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingBipolar Disorder | Cannabis Use | Bipolar I Disorder | Cannabis Use Disorder, Mild | Cannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe | Bipolar II Disorder | Schizoaffective Disorder, Bipolar TypeUnited States
-
Monash UniversityTurning PointCompletedCannabis Use Disorder, Moderate | Cannabis Use Disorder, SevereAustralia
-
McMaster UniversityCenter for Medicinal Cannabis ResearchNot yet recruitingCannabis Use Disorder, Moderate | Cannabis Use Disorder, Severe
-
Ellen HerbstTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Cannabis Use | Drug Use DisorderUnited States
-
VA Office of Research and DevelopmentRecruitingTobacco Use Disorder | Cannabis Use DisorderUnited States
-
Elias DakwarRecruitingAddiction | Cannabis Dependence | Cannabis Use | Substance Abuse | Cannabis Abuse | Cannabis Use DisorderUnited States
-
Dartmouth-Hitchcock Medical CenterNational Institute on Drug Abuse (NIDA)Completed
-
The Scripps Research InstituteNational Institute on Drug Abuse (NIDA)CompletedAlcohol Dependence | Cannabis Dependence | Alcohol Use Disorder | Cannabis Use DisorderUnited States
Clinical Trials on Peer Network Counseling-txt
-
Medical College of WisconsinNational Institute on Drug Abuse (NIDA)CompletedSexually Transmitted Diseases | HIVEl Salvador
-
University of PennsylvaniaNational Institute on Aging (NIA)Completed
-
Brigham and Women's HospitalRecruitingHypertension | Stroke, Acute IschemicUnited States
-
Hennepin Healthcare Research InstituteUniversity of MinnesotaUnknownKidney TransplantUnited States
-
Stanford UniversityJohnson & Johnson; Genentech, Inc.; Amgen; California Breast Cancer Research Program and other collaboratorsCompletedBreast CancerUnited States
-
Hennepin Healthcare Research InstituteUniversity of MinnesotaRecruitingKidney TransplantUnited States
-
Medical College of WisconsinActive, not recruitingHuman Immunodeficiency VirusUnited States
-
Medical College of WisconsinNational Institute of Mental Health (NIMH)Enrolling by invitation
-
Medical College of WisconsinEunice Kennedy Shriver National Institute of Child Health and Human Development...Active, not recruitingAcquired Immunodeficiency Syndrome | HIVBulgaria
-
Medical College of WisconsinCompleted